Advertisement
Screener

ORAGENICS, INC. (OGEN) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

ORAGENICS, INC. Financing Cash Flow

ORAGENICS, INC. (OGEN) reported Financing Cash Flow of -$148.14 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13

  • ORAGENICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$56.13K.
  • ORAGENICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$92.00K, a 101.97% decline year-over-year.
  • ORAGENICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$168.63K.
  • ORAGENICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $12.41M, a 229.68% increase year-over-year.
  • ORAGENICS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $16.78M, a 180.68% increase from fiscal 2024.
  • ORAGENICS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $5.98M, a 2006.07% increase from fiscal 2023.
  • ORAGENICS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $283.88K.
  • ORAGENICS, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$494.92K, a 102.14% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30-$56.13K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
-$148.14K
10-Q · filed 2026-08-13
-$316.77K
derived: sum of 3 quarters · filed 2026-08-13
$12.10M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31-$92.00K
10-Q · filed 2026-05-08
-$260.63K
derived: sum of 2 quarters · filed 2026-05-08
$12.15M
derived: sum of 3 quarters · filed 2026-05-08
$12.02M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31-$168.63K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$12.25M
derived: sum of 2 quarters · filed 2026-03-16
$12.11M
derived: sum of 3 quarters · filed 2026-08-13
$16.78M
10-K · filed 2026-03-16
2025-09-30$12.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$12.28M
derived: sum of 2 quarters · filed 2026-08-13
$16.95M
10-Q · filed 2025-11-07
$16.69M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30-$132.96K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$4.54M
10-Q · filed 2026-08-13
$4.27M
derived: sum of 3 quarters · filed 2026-08-13
$8.04M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$4.67M
10-Q · filed 2026-05-08
$4.41M
derived: sum of 2 quarters · filed 2026-05-08
$8.17M
derived: sum of 3 quarters · filed 2026-05-08
$8.99M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$260.86K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16
$3.50M
derived: sum of 2 quarters · filed 2026-03-16
$4.33M
derived: sum of 3 quarters · filed 2026-03-16
$5.98M
10-K · filed 2026-03-16
2024-09-30$3.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$4.59M
derived: sum of 2 quarters · filed 2025-11-07
$6.24M
10-Q · filed 2025-11-07
$6.06M
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30$821.16K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
$2.47M
10-Q · filed 2025-08-08
$2.29M
derived: sum of 3 quarters · filed 2025-08-08
$3.03M
derived: sum of 4 quarters · filed 2025-08-08
2024-03-31$1.65M
10-Q · filed 2025-05-09
$1.47M
derived: sum of 2 quarters · filed 2025-05-09
$2.20M
derived: sum of 3 quarters · filed 2025-05-09
$2.10M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31-$180.60K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
$551.52K
derived: sum of 2 quarters · filed 2025-03-14
$443.63K
derived: sum of 3 quarters · filed 2025-03-14
$283.88K
10-K · filed 2025-03-14
2023-09-30$732.12K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13
$624.23K
derived: sum of 2 quarters · filed 2024-11-13
$464.48K
10-Q · filed 2024-11-13
$376.48K
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30-$107.89K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
-$267.64K
10-Q · filed 2024-08-09
-$355.63K
derived: sum of 3 quarters · filed 2024-08-09
-$459.14K
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31-$159.75K
10-Q · filed 2024-05-15
-$247.75K
derived: sum of 2 quarters · filed 2024-05-15
-$351.25K
derived: sum of 3 quarters · filed 2024-05-15
-$473.43K
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$88.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
-$191.50K
derived: sum of 2 quarters · filed 2024-03-29
-$313.68K
derived: sum of 3 quarters · filed 2024-03-29
-$494.92K
10-K · filed 2024-03-29
2022-09-30-$103.50K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$225.68K
derived: sum of 2 quarters · filed 2023-11-09
-$406.92K
10-Q · filed 2023-11-09
-$585.76K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30-$122.17K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11
-$303.42K
10-Q · filed 2023-08-11
-$482.26K
derived: sum of 3 quarters · filed 2023-08-11
-$504.17K
derived: sum of 4 quarters · filed 2023-08-11
2022-03-31-$181.24K
10-Q · filed 2023-05-12
-$360.08K
derived: sum of 2 quarters · filed 2023-05-12
-$381.99K
derived: sum of 3 quarters · filed 2023-05-12
-$229.74K
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31-$178.84K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-04-17
-$200.75K
derived: sum of 2 quarters · filed 2023-04-17
-$48.49K
derived: sum of 3 quarters · filed 2023-04-17
$23.14M
10-K · filed 2023-04-17
2021-09-30-$21.91K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2023-04-14
$130.35K
derived: sum of 2 quarters · filed 2023-04-14
$23.32M
10-Q/A · filed 2023-04-14
$23.92M
10-Q · filed 2021-11-15
$34.55M
derived: sum of 4 quarters · filed 2023-04-14
2021-06-30$152.26K
derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2023-04-14
$23.34M
10-Q/A · filed 2023-04-14
$34.57M
derived: sum of 3 quarters · filed 2023-04-14
$39.65M
derived: sum of 4 quarters · filed 2023-04-14
2021-03-31$23.19M
10-Q/A · filed 2023-04-14
$34.42M
derived: sum of 2 quarters · filed 2023-04-14
$39.50M
derived: sum of 3 quarters · filed 2023-04-14
$39.59M
derived: sum of 4 quarters · filed 2023-04-14
2020-12-31$11.23M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-29
$16.31M
derived: sum of 2 quarters · filed 2022-07-29
$16.40M
derived: sum of 3 quarters · filed 2022-07-29
$16.32M
10-K/A · filed 2022-07-29
2020-09-30$5.08M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$5.17M
derived: sum of 2 quarters · filed 2021-11-15
$5.10M
10-Q · filed 2021-11-15
$5.02M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30$89.74K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16
$16.72K
10-Q · filed 2021-08-16
-$56.83K
derived: sum of 3 quarters · filed 2021-08-16
-$106.83K
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$73.02K
10-Q · filed 2021-05-03
-$146.57K
derived: sum of 2 quarters · filed 2021-05-03
-$196.57K
derived: sum of 3 quarters · filed 2021-05-03
-$326.57K
derived: sum of 4 quarters · filed 2021-05-03
2019-12-31-$73.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$123.55K
derived: sum of 2 quarters · filed 2021-03-01
-$253.55K
derived: sum of 3 quarters · filed 2021-03-01
$11.10M
10-K · filed 2021-03-01
2019-09-30-$50.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10
-$180.00K
derived: sum of 2 quarters · filed 2020-11-10
$11.17M
10-Q · filed 2020-11-10
$20.61M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30-$130.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14
$11.22M
10-Q · filed 2020-08-14
$20.66M
derived: sum of 3 quarters · filed 2020-08-14
$33.05M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31$11.35M
10-Q · filed 2020-05-15
$20.79M
derived: sum of 2 quarters · filed 2020-05-15
$33.18M
derived: sum of 3 quarters · filed 2020-05-15
$34.64M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$9.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-04
$21.82M
derived: sum of 2 quarters · filed 2020-03-04
$23.29M
derived: sum of 3 quarters · filed 2020-03-04
$23.25M
10-K · filed 2020-03-04
2018-09-30$12.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14
$13.85M
derived: sum of 2 quarters · filed 2019-11-14
$13.81M
10-Q · filed 2019-11-14
$18.41M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30$1.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14
$1.42M
10-Q · filed 2019-08-14
$6.02M
derived: sum of 3 quarters · filed 2019-08-14
$8.20M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31-$41.63K
10-Q · filed 2019-05-13
$4.56M
derived: sum of 2 quarters · filed 2019-05-13
$6.73M
derived: sum of 3 quarters · filed 2019-05-13
$8.41M
derived: sum of 4 quarters · filed 2019-05-13
2017-12-31$4.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29
$6.78M
derived: sum of 2 quarters · filed 2019-03-29
$8.45M
derived: sum of 3 quarters · filed 2019-03-29
$8.45M
10-K · filed 2019-03-29
2017-09-30$2.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13
$3.85M
derived: sum of 2 quarters · filed 2018-11-13
$3.85M
10-Q · filed 2018-11-13
$4.79M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$1.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13
$1.67M
10-Q · filed 2018-08-13
$2.61M
derived: sum of 3 quarters · filed 2018-08-13
$3.56M
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31-$4.95K
10-Q · filed 2018-05-15
$934.49K
derived: sum of 2 quarters · filed 2018-05-15
$1.88M
derived: sum of 3 quarters · filed 2018-05-15
$4.48M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31$939.44K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16
$1.89M
derived: sum of 2 quarters · filed 2018-02-16
$4.49M
derived: sum of 3 quarters · filed 2018-02-16
$4.45M
10-K · filed 2018-02-16
2016-09-30$949.87K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$3.55M
derived: sum of 2 quarters · filed 2017-10-31
$3.51M
10-Q · filed 2017-10-31
$3.47M
derived: sum of 4 quarters · filed 2017-10-31
2016-06-30$2.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14
$2.56M
10-Q · filed 2017-08-14
$2.52M
derived: sum of 3 quarters · filed 2017-08-14
$2.48M
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31-$33.95K
10-Q · filed 2017-05-15
-$80.11K
derived: sum of 2 quarters · filed 2017-05-15
-$114.43K
derived: sum of 3 quarters · filed 2017-05-15
2015-12-31-$46.16K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
-$80.48K
derived: sum of 2 quarters · filed 2017-02-27
-$159.95K
10-K · filed 2017-02-27
2015-09-30-$34.32K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14
-$113.79K
10-Q · filed 2016-11-14
2015-06-30-$79.47K
10-Q · filed 2016-08-15
2013-09-30$3.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25
$3.90M
derived: sum of 2 quarters · filed 2013-10-25
$3.90M
10-Q · filed 2013-10-25
$3.82M
derived: sum of 4 quarters · filed 2013-10-25
2013-06-30$23.80K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12
$29.06K
10-Q · filed 2013-08-12
-$50.77K
derived: sum of 3 quarters · filed 2013-08-12
$11.75M
derived: sum of 4 quarters · filed 2013-10-25
2013-03-31$5.26K
10-Q · filed 2013-05-15
-$74.57K
derived: sum of 2 quarters · filed 2013-05-15
$11.73M
derived: sum of 3 quarters · filed 2013-10-25
$13.04M
derived: sum of 4 quarters · filed 2013-10-25
2012-12-31-$79.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26
$11.73M
derived: sum of 2 quarters · filed 2013-10-25
$13.04M
derived: sum of 3 quarters · filed 2013-10-25
$14.98M
10-K · filed 2013-03-26
2012-09-30$11.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-25
$13.12M
derived: sum of 2 quarters · filed 2013-10-25
$15.06M
10-Q · filed 2013-10-25
$16.62M
derived: sum of 4 quarters · filed 2013-10-25
2012-06-30$1.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12
$3.25M
10-Q · filed 2013-08-12
$4.81M
derived: sum of 3 quarters · filed 2013-08-12
$6.33M
derived: sum of 4 quarters · filed 2013-08-12
2012-03-31$1.94M
10-Q · filed 2013-05-15
$3.50M
derived: sum of 2 quarters · filed 2013-05-15
$5.02M
derived: sum of 3 quarters · filed 2013-05-15
$6.43M
derived: sum of 4 quarters · filed 2013-05-15
2011-12-31$1.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26
$3.08M
derived: sum of 2 quarters · filed 2013-03-26
$4.49M
derived: sum of 3 quarters · filed 2013-03-26
$5.53M
10-K · filed 2013-03-26
2011-09-30$1.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14
$2.92M
derived: sum of 2 quarters · filed 2012-11-14
$3.97M
10-Q · filed 2012-11-14
$5.28M
derived: sum of 4 quarters · filed 2012-11-14
2011-06-30$1.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10
$2.45M
10-Q · filed 2012-08-10
$3.76M
derived: sum of 3 quarters · filed 2012-08-10
$5.62M
derived: sum of 4 quarters · filed 2012-08-10
2011-03-31$1.05M
10-Q · filed 2012-05-15
$2.36M
derived: sum of 2 quarters · filed 2012-05-15
$4.21M
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16
$3.16M
derived: sum of 2 quarters · filed 2012-04-16
$6.37M
10-K · filed 2012-04-16
2010-09-30$1.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$5.06M
10-Q · filed 2011-11-14
2010-06-30$3.20M
10-Q · filed 2011-08-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02